Top 10 Best-Rated Biotech Stocks: QGEN, CELG, LIFE, GILD, AMGN, HGSI, ICLR, RDEA, UTHR, CVD (Jul 27, 2010)

Below are the top 10 best-rated Biotechnology stocks, based on the number of positive ratings by brokerage analysts.

Qiagen NV (NASDAQ:QGEN) is the 1st best-rated stock in this segment of the market. It is rated positively by 20 brokerage analysts. It is covered by 30 brokerage analysts. Celgene Corporation (NASDAQ:CELG) is the 2nd best-rated stock in this segment of the market. It is rated positively by 19 brokerage analysts. It is covered by 21 brokerage analysts. Life Technologies Corp. (NASDAQ:LIFE) is the 3rd best-rated stock in this segment of the market. It is rated positively by 15 brokerage analysts. It is covered by 18 brokerage analysts. Gilead Sciences, Inc. (NASDAQ:GILD) is the 4th best-rated stock in this segment of the market. It is rated positively by 15 brokerage analysts. It is covered by 25 brokerage analysts. Amgen, Inc. (NASDAQ:AMGN) is the 5th best-rated stock in this segment of the market. It is rated positively by 14 brokerage analysts. It is covered by 21 brokerage analysts.

Human Genome Sciences (NASDAQ:HGSI) is the 6th best-rated stock in this segment of the market. It is rated positively by 13 brokerage analysts. It is covered by 14 brokerage analysts. ICON plc (ADR) (NASDAQ:ICLR) is the 7th best-rated stock in this segment of the market. It is rated positively by 13 brokerage analysts. It is covered by 16 brokerage analysts. Ardea Biosciences, Inc. (NASDAQ:RDEA) is the 8th best-rated stock in this segment of the market. It is rated positively by 12 brokerage analysts. It is covered by 12 brokerage analysts. United Therapeutics Corporation (NASDAQ:UTHR) is the 9th best-rated stock in this segment of the market. It is rated positively by 12 brokerage analysts. It is covered by 15 brokerage analysts. Covance Inc. (NYSE:CVD) is the 10th best-rated stock in this segment of the market. It is rated positively by 12 brokerage analysts. It is covered by 18 brokerage analysts.